Craig-Hallum Upgrades Alere (ALR) to Buy

Go back to Craig-Hallum Upgrades Alere (ALR) to Buy

Alere (ALR) Receives Extension from Lenders to File 10-K; Updates on Abbott (ABT) Merger, 'Serious Concerns' Noted

April 29, 2016 9:27 AM EDT

Alere Inc. (NYSE: ALR) announced that it recently obtained the requisite lender approval under its credit facility for an extension to file its Annual Report on Form 10-K for the period ending December 31, 2015. Details of the extension and other terms of the agreement are included in an amendment to Alere's credit facility, which Alere filed with the Securities Exchange Commission as an exhibit to a Current Report on Form 8-K. Alere continues to work diligently, with the assistance of its independent auditors, to conclude its accounting review and file its Form 10-K as... More

AbbVie (ABBV) CEO Declines to Comment on Alere (ALR) - Conf. Call

April 28, 2016 9:54 AM EDT

Alere (NYSE: ALR) is on watch as AbbVie (NYSE: ABBV) CEO says it isn't appropriate to comment on the company during the quarterly conference call, according to Bloomberg headlines.

... More

Leerink Partners Upgrades Alere (ALR) to Outperform

April 28, 2016 7:49 AM EDT

Leerink Partners upgraded Alere (NYSE: ALR) from Market Perform to Outperform with a price target of $56.00.

Analyst Dan Leonard commented, "We are upgrading ALR shares from Market Perform to Outperform with a view that Abbott (ABT, MP) will consummate its proposed acquisition at $56 per... More